Pellagra and peripheral neuropathy secondary to tuberculosis treatment
Authors:
Open Access
- 2 May 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 116 (8) , 696-698
Abstract
Jingqiao Wang, Jiaqi Yu, Xiaoming Huang; Pellagra and peripheral neuropathy secondary to tuberculosis treatment, QJM: An International Journal of Medicine, , hcKeywords
Funding Information
- National High Level Hospital Clinical Research Funding (2022-P UMCH-B-045)
This publication has 6 references indexed in Scilit:
- Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control studyThe Lancet Global Health, 2022
- Preventing pellagra during isoniazid preventive treatmentThe Lancet Global Health, 2022
- Isoniazid-induced pellagra in a patient with Crohn's diseaseClinical Case Reports, 2020
- Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in ChinaJournal of Global Antimicrobial Resistance, 2020
- Ethionamide-induced PellagraJournal of Tropical Pediatrics, 2015
- Drug‐Induced Peripheral NeuropathyBasic & Clinical Pharmacology & Toxicology, 2014